Apocynin attenuates oxidative stress and hypertension in young spontaneously hypertensive rats independent of ADMA/NO pathway

Free Radical Research

Volumn 46, Issue 1, 2012, Pages 68-76

  Tain, You Lin ^a,b   Hsu, Chien Ning ^b   Huang, Li Tung ^a   Lau, Ying Tung ^c  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^c CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

Apocynin; Asymmetric dimethylarginine; Hypertension; NADPH oxidase; Nitric oxide

Indexed keywords

APOCYNIN; HYDROGEN PEROXIDE; N(G),N(G) DIMETHYLARGININE; NITRIC OXIDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATTENUATION; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ESSENTIAL HYPERTENSION; HEART WEIGHT; KIDNEY; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; OXIDATIVE STRESS; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; SYSTOLIC BLOOD PRESSURE; WISTAR KYOTO RAT;

ACETOPHENONES; ANIMALS; ANTIOXIDANTS; ARGININE; HYPERTENSION; MALE; NADPH OXIDASE; NITRIC OXIDE; OXIDATIVE STRESS; RANDOM ALLOCATION; RATS; RATS, INBRED SHR; RATS, INBRED WKY; REACTIVE OXYGEN SPECIES;

EID: 83055196805     PISSN: 10715762     EISSN: 10292470     Source Type: Journal    
DOI: 10.3109/10715762.2011.639069     Document Type: Article

References (39)

1. Lee MY, Griendling KK. Redox signaling, vascular function, and hypertension. Antioxid Redox Signal 2008;10:1045-1059. (Pubitemid 351451709)
2. Paravicini TM, Touyz RM. Redox signaling in hypertension. Cardiovasc Res 2006;71:247-258.
3. Wilcox CS. Oxidative stress and nitric oxide defi ciency in the kidney: a critical link to hypertension? Am J Physiol Regul Integr Comp Physiol 2005;289:R913-R935. (Pubitemid 41397037)
4. Williams HC, Griendling KK. NADPH oxidase inhibitors: new antihypertensive agents? J Cardiovasc Pharmacol 2007; 50:9-16. (Pubitemid 47220441)
5. Touyz RM. Apocynin, NADPH oxidase, and vascular cells: a complex matter. Hypertension 2008;51:172-174. (Pubitemid 351159922)
6. Taylor NE, Glocka P, Liang M, Cowley AW Jr. NADPH oxidase in the renal medulla causes oxidative stress and contributes to salt-sensitive hypertension in Dahl S rats. Hypertension 2006;47:692-698. (Pubitemid 43740240)
7. Jin L, Beswick RA, Yamamoto T, Palmer T, Taylor TA, Pollock JS, et al. Increased reactive oxygen species contributes to kidney injury in mineralocorticoid hypertensive rats. J Physiol Pharmacol 2006;57:343-357. (Pubitemid 44543871)
8. Hu L, Zhang Y, Lim PS, Miao Y, Tan C, McKenzie KU, et al. Apocynin but not L-arginine prevents and reverses dexamethasone-induced hypertension in the rat. Am J Hypertens 2006;19:413-418.
9. Virdis A, Neves MF, Amiri F, Touyz RM, Schiffrin EL. Role of NAD(P)H oxidase on vascular alterations in angiotensin II-infused mice. J Hypertens 2004;22:535-542. (Pubitemid 38368487)
10. Bäumer AT, Krüger CA, Falkenberg J, Freyhaus HT, Rösen R, Fink K, Rosenkranz S. The NAD(P)H oxidase inhibitor apocynin improves endothelial NO/superoxide balance and lowers effectively blood pressure in spontaneously hypertensive rats: comparison to calcium channel blockade. Clin Exp Hypertens 2007;29:287-299. (Pubitemid 47123899)
11. Pechánová O, Jendeková L, Vranková S. Effect of chronic apocynin treatment on nitric oxide and reactive oxygen species production in borderline and spontaneous hypertension. Pharmacol Rep 2009;61:116-122.
12. Iliescu R, Cucchiarelli VE, Yanes LL, Iles JW, Reckelhoff JF. Impact of androgen-induced oxidative stress on hypertension in male SHR. Am J Physiol Regul Integr Comp Physiol 2007;292:R731-R735. (Pubitemid 46207723)
13. Paliege A, Pasumarthy A, Mizel D, Yang T, Schnermann J, Bachmann S. Effect of apocynin treatment on renal expression of COX-2, NOS1, and renin in Wistar-Kyoto and spontaneously hypertensive rats. Am J Physiol Regul Integr Comp Physiol 2006;290:R694-R700.
14. Schl ü ter T, Steinbach AC, Steffen A, Rettig R, Grisk O. Apocynin-induced vasodilation involves Rho kinase inhibition but not NADPH oxidase inhibition. Cardiovasc Res 2008; 80:271-279.
15. Kopkan L, Husková Z, Vanourková Z, Thumová M, Skaroupková P, Mal ý J, et al. Reduction of oxidative stress does not attenuate the development of angiotensin II-dependent hypertension in Ren-2 transgenic rats. Vascul Pharmacol 2009;51:175-181.
16. Liu F, Wei CC, Wu SJ, Chenier I, Zhang SL, Filep JG, et al. Apocynin attenuates tubular apoptosis and tubulointerstitial fi brosis in transgenic mice independent of hypertension. Kidney Int 2009;75:156-166.
17. Leiper J, Vallance P. Biological signifi cance of endogenous methylarginines that inhibit nitric oxide synthases. Cardiovasc Res 1999;43:542-548. (Pubitemid 29369253)
18. Bö g er RH. The emerging role of asymmetric dimethylarginine as a novel cardiovascular risk factor. Cardiovasc Res 2003; 59:824-833. (Pubitemid 38366238)
19. Sasser JM, Moningka NC, Cunningham MW Jr, Croker B, Baylis C. Asymmetric dimethylarginine in angiotensin II-induced hypertension. Am J Physiol Regul Integr Comp Physiol 2010;298:R740-R746.
20. Tain YL, Huang LT, Lin IC, Lau YT, Lin CY. Melatonin prevents hypertension and increased asymmetric dimethylarginine in young spontaneous hypertensive rats. J Pineal Res 2010;49:390-398.
21. Teerlink T, Luo Z, Palm F, Wilcox CS. Cellular ADMA: regulation and action. Pharmacol Res 2009;60:448-460.
22. Druhan LJ, Forbes SP, Pope AJ, Chen CA, Zweier JL, Cardounel AJ. Regulation of eNOS-derived superoxide by endogenous methylarginines. Biochemistry 2008;47:7256-7263. (Pubitemid 351956374)
23. Luo Z, Teerlink T, Griendling K, Aslam S, Welch WJ, Wilcox CS. Angiotensin II and NADPH oxidase increase ADMA in vascular smooth muscle cells. Hypertension 2010;56:498-504.
24. Veresh Z, Racz A, Lotz G, Koller A. ADMA impairs nitric oxide-mediated arteriolar function due to increased superoxide production by angiotensin II-NAD(P)H oxidase pathway. Hypertension 2008;52:960-966.
25. Tain YL, Kao YH, Hsieh CS, Chen CC, Sheen JM, Lin IC, Huang LT. Melatonin blocks oxidative stress-induced increased asymmetric dimethylarginine. Free Radic Biol Med 2010;49:1088-1098.
26. Tain YL, Ghosh S, Krieg RJ, Baylis C. Reciprocal changes of renal neuronal nitric oxide synthase-αand-βassociated with renal progression in a neonatal 5/6 nephrectomized rat model. Pediatr Neonatol 2011;52:66-72.
27. Kitada M, Koya D, Sugimoto T, Isono M, Araki S, Kashiwagi A, Haneda M. Translocation of glomerular p47phox and p67phox by protein kinase C-beta activation is required for oxidative stress in diabetic nephropathy. Diabetes 2003; 52:2603-2614. (Pubitemid 37210551)
28. Tain YL, Baylis C. Determination of dimethylarginine dimethylaminohydrolase activity in the kidney. Kidney Int 2007; 72:886-889. (Pubitemid 47462078)
29. Tain YL, Freshour G, Dikalova A, Griendling K, Baylis C. Vitamin E reduces glomerulosclerosis, restores renal neuronal NOS, and suppresses oxidative stress in the 5/6 nephrectomized rat. Am J Physiol Renal Physiol 2007;292:F1404-F1410. (Pubitemid 46701867)
30. Bode-Bö g er SM, Scalera F, Ignarro LJ. The L-arginine paradox: importance of the L-arginine/asymmetrical dimethylarginine ratio. Pharmacol Ther 2007;114:295-306. (Pubitemid 46843253)
31. Pinto YM, Paul M, Ganten D. Lessons from rat models of hypertension: from Goldblatt to genetic engineering. Cardiovasc Res 1998;39:77-88. (Pubitemid 28322381)
32. Gallego-Delgado J, Lazaro A, Osende JI, Esteban V, Barderas MG, Gomez-Guerrero C, et al. Proteomic analysis of early left ventricular hypertrophy secondary to hypertension: modulation by antihypertensive therapies. J Am Soc Nephrol 2006;17:S159-S164. (Pubitemid 44865242)
33. Ren J, Jefferson L, Sowers JR, Brown RA. Infl uence of age on contractile response to insulin-like growth factor 1 in ventricular myocytes from spontaneously hypertensive rats. Hypertension 1999;34:1215-1222. (Pubitemid 30002385)
34. Cruzado MC, Risler NR, Miatello RM, Yao G, Schiffrin EL, Touyz RM. Vascular smooth muscle cell NAD(P)H oxidase activity during the development of hypertension: effect of angiotensin II and role of insulin-like growth factor-1 receptor transactivation. Am J Hypertens 2005;18:81-87. (Pubitemid 40187353)
35. Biswas SK, de Faria JB. Which comes fi rst: renal infl ammation or oxidative stress in spontaneously hypertensive rats? Free Radic Res 2007;41:216-224. (Pubitemid 46992872)
36. Zhou X, Bohlen HG, Miller SJ, Unthank JL. NAD(P)H oxidase-derived peroxide mediates elevated basal and impaired fl ow-induced NO production in SHR mesenteric arteries in vivo. Am J Physiol Heart Circ Physiol 2008;295:H1008-H1016.
37. Li XH, Peng J, Tan N, Wu WH, Li TT, Shi RZ, Li YJ. Involvement of asymmetric dimethylarginine and Rho kinase in the vascular remodeling in monocrotaline-induced pulmonary hypertension. Vascul Pharmacol 2010;53:223-229.
38. Koeners MP, van Faassen EE, Wesseling S, de Sain-van der Velden M, Koomans HA, Braam B, Joles JA. Maternal supplementation with citrulline increases renal nitric oxide in young spontaneously hypertensive rats and has long-term antihypertensive effects. Hypertension 2007;50:1077-1084. (Pubitemid 350172929)
39. Castor LR, Locatelli KA, Ximenes VF. Pro-oxidant activity of apocynin radical. Free Radic Biol Med 2010;48:1636-1643.